Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. 2009

Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
Birla Institute of Technology and Science, Pilani, India. dalipk@bits-pilani.ac.in

A series of 3,5-disubstituted-1,2,4-oxadiazoles were synthesized and evaluated for their in vitro anti-proliferative activities against various cancer cell lines. Formation of 1,2,4-oxadiazole ring was accomplished by the reaction of amidoxime with carboxylic acids. The in vitro cytotoxic effects of 3,5-disubstituted-1,2,4-oxadiazoles have been demonstrated across a wide array of tumor cell types and a few compounds exhibited specificity towards pancreatic (3f, 3h, 3j, and 3k) and prostate (3n) cancer cells. Among the prepared 3,5-disubstituted-1,2,4-oxadiazoles, compound 3n is the most selective (>450-fold) and compound 3p is the most cytotoxic (10nM) against prostate cancer cell lines.

UI MeSH Term Description Entries
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
August 2012, Tetrahedron letters,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
September 1985, Journal of medicinal chemistry,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
November 2008, Archiv der Pharmazie,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
July 2006, Molecules (Basel, Switzerland),
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
October 2016, ACS combinatorial science,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
June 2012, Drug discoveries & therapeutics,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
December 2012, Acta chimica Slovenica,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
March 2019, European journal of medicinal chemistry,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
October 2010, European journal of medicinal chemistry,
Dalip Kumar, and Gautam Patel, and Emmanuel O Johnson, and Kavita Shah
February 2022, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!